Growing Complex Generic Application Load May Force US FDA Staffing Changes

 
• By Derrick Gingery

Complex products are slowly gaining a larger share of ANDA submission and approval totals, which could mean the FDA has to adapt its in-house expertise to compensate.

Glucagon kit
FDA research helped clear a pathway for approval of a generic glucagon product. • Source: Alamy

More from Generics

More from Biosimilars & Generics